Applications for Registration

Tristan Ahtone filed this request with the Drug Enforcement Administration of the United States of America.
Tracking #

22-00166-F

22-00158-F

22-00166-F

Status
Rejected

From: Tristan Ahtone

To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

All Schedule I applications for registration under the controlled substances act received by the DEA from January I, 2016 to present. This request also seeks records of the DEA's approval or denial of any and all Schedule 1 applications for registration under the controlled substances act it has received during that same time period.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Tristan Ahtone

From: Drug Enforcement Administration

Dear Mr. Ahtone: This is to acknowledge receipt of your Freedom of Information Act/Privacy Act (FOIA/PA) request by the Drug Enforcement Administration, FOIA/PA Section.  This response is a courtesy reply.  It does not replace the acknowledgement letter that will be sent to you once your request has been reviewed by our Intake Unit.  Please note, requests are handled in the order they are received.  We will advise you if any additional information is required. Please be advised, due to necessary operational changes as a result of the national emergency concerning the novel coronavirus disease (COVID-19) outbreak, there may be some delay in the processing of your request. You may wish to visit DEA’s public facing website at or the FOIA Library available (http://www.dea.gov/) www.dea.gov at FOIA Library | DEA.gov to determine if the information you seek is already available to the public. You may contact our FOIA Public Liaison at (571) 776-3139 for any further assistance and to discuss any aspect of your request.  Additionally, you may contact the Office of Government Information Services (OGIS) at the National Archives and Records Administration to inquire about the FOIA mediation services they offer.  The contact information for OGIS is as follows: Office of Government Information Services, National Archives and Records Administration, Room 2510, 8601 Adelphi Road, College Park, Maryland 20740-6001; e-mail at ogis@nara.gov; telephone at (202) 741-5770; toll free at 1-877-684-6448; or facsimile at (202) 741-5769. If you have any questions regarding this email, you may contact our FOIA Requester Service Center at (571) 776-2300.  Thank you for your patience as we work to complete the processing of your request. Respectfully, Jennifer Chavez FOIA/PA Specialist
Intake Unit FOIA/PA Section Drug Enforcement Administration Telephone: (571) 776-3261 E-mail: Jennifer.M.CoreasChavez@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.

From: Muckrock Staff

To Whom It May Concern:

I wanted to follow up on the following Freedom of Information Act request, copied below, and originally submitted on Nov. 23, 2021. Please let me know when I can expect to receive a response. You had assigned it reference number #22-00166-F.

Thanks for your help, and let me know if further clarification is needed.

From: Drug Enforcement Administration

Dear Tristan Ahtone: This e-mail responds to your Freedom of Information Act/Privacy Act (FOIA/PA) request dated November 23, 2021, received by the Drug Enforcement Administration (DEA), FOIA/PA Unit, seeking access to DEA records.  Your request has been opened and assigned the following case number : 22-00166-F. Please include this case number when communicating with this office. For your information, this office assigns incoming requests to one of three tracks:  simple, complex, or expedited.  Each request is then handled on a first-in, first-out basis in relation to other requests in the same track.  Simple requests usually receive a response in approximately one month, whereas complex requests necessarily take longer.  At this time, your request has been assigned to the complex track.  You may wish to narrow the scope of your request to limit the number of potentially responsive records or agree to an alternative time frame for processing, should records be located; or you may wish to await the completion of our records search to discuss either of these options. We regret the necessity of this delay, but please be assured that your request will be processed as soon as possible.  If you have any questions or wish to discuss reformulation or an alternative time frame for the processing of your request, you may contact FOIA/PA Unit representative Sandra L. Seidel at (571) 776-3317 or via e-mail at Sandra.L.Seidel@dea.gov, our FOIA Requester Service Center at (571) 776-2300, or e-mail your correspondence to DEA.FOIA@dea.gov. In addition, you may wish to visit our website at www.dea.gov to determine if the information you are requesting is already available to the public.  You may contact our FOIA Public Liaison at (571) 776-2300 for any further assistance and to discuss any aspect of your request .  Additionally, you may contact the Office of Government Information Services (OGIS) at the National Archives and Records Administration to inquire about the FOIA mediation services they offer.  The contact information for OGIS is as follows: Office of Government Information Services, National Archives and Records Administration, Room 2510, 8601 Adelphi Road, College Park, Maryland 20740-6001; e-mail at ogis@nara.gov; telephone at (202) 741-5770; toll free at 1-877-684-6448; or facsimile at (202) 741-5769. Sincerely, Sandra L. Seidel FOIA/PA Specialist
Intake Sub-Unit FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3317 E-mail: Sandra.L.Seidel@dea.gov PRIVACY ACT NOTICE:  This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 ( U.S.C. § 552a).  Any use of this information by anyone other than the intended recipient is prohibited .  If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail.  The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.

From: Drug Enforcement Administration

Dear Tristan Ahtone: Further to your Freedom of Information Act/Privacy Act (FOIA/PA) request 22-00166-F.  After review of your request for all Schedule I Registrant Applications.  For clarification purposes, are you referring to DEA’s Forms-224, 225, 363, 510 for registration and renewals? Also, can you provide a date range for the search to narrow the perimeters and amount of data to be retrieved?

We are working to process your request as soon as possible, please provide us with a response so within 10 business days. We apologize in advance for the delay in processing. Your continued patience in this matter is  greatlyappreciated.
Sincerely, Sandra L. Seidel FOIA/PA Specialist Intake Sub-Unit
FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3317 E-mail: Sandra.L.Seidel@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.

From: Drug Enforcement Administration

Acknowledge with thanks,

Sandra L. Seidel
IBSS Corp. FOIA Paralegal II
Intake Sub-Unit, Freedom of Information and Privacy Act Unit (CCAR)
U.S. Department of Justice
Drug Enforcement Administration
Attn: FOIA/PA Unit
8701 Morrissette Drive
Springfield, Virginia 22152
Desk: (571) 776-3317
Email: Sandra.L.Seidel@dea.gov<mailto:Sandra.L.Seidel@dea.gov>

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.

From: Drug Enforcement Administration

Good morning,

In response to your request, please be advised that we are in receipt of your status inquiry regarding the pending FOIA request for 22-00158-F. Due to the large number of requests received by DEA for disclosure of records pursuant to the Acts, and due to the limited resources available to process such requests, DEA has adopted a "first-in, first-out" practice of processing all incoming requests.

We are working to process your request as soon as possible and you will receive additional correspondence as processing is completed.

Your continued patience in this matter is greatly appreciated.

With best regards,

Sandra L. Seidel
IBSS Corp. FOIA Paralegal II
Intake Sub-Unit, Freedom of Information and Privacy Act Unit (CCAR)
FOIA and Information Law Section
Drug Enforcement Administration
Attn: FOIA/PA Unit
8701 Morrissette Drive
Springfield, Virginia 22152
Desk: (571) 776-3317
Email: Sandra.L.Seidel@dea.gov<mailto:Sandra.L.Seidel@dea.gov>

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.

From: Drug Enforcement Administration

Thank you for your email concerning the status of your pending FOIA request which our office received on November 23, 2021 . We apologize for the delay in responding to your request. This office has a backlog of approximately 1,800 requests, and we have limited resources to process requests. This has impacted our ability to respond to your request in a timelier manner.

We are currently working to process your request as soon as possible and you will receive additional correspondence as processing is completed.

Your continued patience in this matter is greatly appreciated.

With best regards,

Sandra L. Seidel
IBSS Corp. FOIA Paralegal II
Intake Sub-Unit, Freedom of Information and Privacy Act Unit (CCAR)
FOIA and Information Law Section
Drug Enforcement Administration
Attn: FOIA/PA Unit
8701 Morrissette Drive
Springfield, Virginia 22152
Desk: (571) 776-3317
Email: Sandra.L.Seidel@dea.gov<mailto:Sandra.L.Seidel@dea.gov>

PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.

From: Drug Enforcement Administration

Dear Tristan Ahtone: Please see the attached response to your Freedom of Information Act/Privacy Act (FOIA/PA) request 22-00158-F.  If you have any questions, please contact our FOIA Requester Service Center at (571) 776-2300. Sincerely,
FOIA/PA Unit
FOIA & Information Law Section
Office of Chief Counsel
Drug Enforcement Administration PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.

From: Drug Enforcement Administration

Dear Tristan Ahtone: Please see the attached response to your Freedom of Information Act/Privacy Act (FOIA/PA) request 22-00166-F.  If you have any questions, please contact our FOIA Requester Service Center at (571) 776-2300. Sincerely,
FOIA/PA Unit
FOIA & Information Law Section
Office of Chief Counsel
Drug Enforcement Administration PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.